Raphael Seiler

Dr. Raphael Seiler


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SFSimone Faller
Simone Faller
RSRaphael Seiler
Raphael Seiler
RDRosa Donus
Rosa Donus
HEHelen Engelstaedter
Helen Engelstaedter
AHAlexander Hoetzel
Alexander Hoetzel
SSSashko G. Spassov
Sashko G. Spassov
Although essential in critical care medicine, mechanical ventilation often results in ventilator-induced lung injury. Low concentrations of hydrogen sulfide have been proven to have anti-inflammatory and anti-oxidative effects in the lung. The aim of this study was to analyze the kinetic effects of pre- and posttreatment with hydrogen sulfide in order to prevent lung injury as well as inflammatory and oxidative stress upon mechanical ventilation. Mice were either non-ventilated or mechanically ventilated with a tidal volume of 12 ml/kg for 6 h. Pretreated mice inhaled hydrogen sulfide in low dose for 1, 3, or 5 h prior to mechanical ventilation. Posttreated mice were ventilated with air followed by ventilation with hydrogen sulfide in various combinations. In addition, mice were ventilated with air for 10 h, or with air for 5 h and subsequently with hydrogen sulfide for 5 h. Histology, interleukin-1β, neutrophil counts, and reactive oxygen species formation were examined in the lungs. Both pre-and posttreatment with hydrogen sulfide time-dependently reduced or even prevented edema formation, gross histological damage, neutrophil influx and reactive oxygen species production in the lung. These results were also observed in posttreatment, when the experimental time was extended and hydrogen sulfide administration started as late as after 5 h air ventilation. In conclusion, hydrogen sulfide exerts lung protection even when its application is limited to a short or delayed period. The observed lung protection is mediated by inhibition of inflammatory and oxidative signaling.

22 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSRaphael Seiler
Raphael Seiler
RSRobin Stenzel
Robin Stenzel
VWViktoria Weixler
Viktoria Weixler
MMMilena Muiznieks
Milena Muiznieks
MGMarina Gürtner
Marina Gürtner
PMPeter Murin
Peter Murin
Limited magnetic resonance imaging (MRI) data on autograft dilatation following the Ross procedure in congenital cohorts presents challenges in understanding its evolution and impact on clinical outcomes. This study, spanning from February 2003 to December 2022, included patients under 40 years at the time of the Ross procedure, with MRI follow-ups assessing dimensions at key aortic sites. Among 307 patients, 132 MRIs were analyzed from 76 individuals, revealing that autograft z-scores increase primarily with time post-procedure (Coef. 0.13; 95% CI:0.051–0.216; P = 0.002). Additionally, older patients at the time of surgery showed larger ascending aortic dimensions (Coef. 0.13; 95% CI:0.099–0.165; P = 0.001). Notably, autograft dilation at the sinus of Valsalva significantly predicted higher reintervention risks (HR 1.57; 95% CI:1.21–2.04; P = 0.001). Surgical reinforcement techniques of the autograft, via subcoronary implantation or external support, prevented such dilation (P < 0.001) and mitigated aortic regurgitation. In conclusion, our model predicted autograft dilation over time in patients after Ross procedure, aiding clinicians in making data-driven decisions regarding the optimal timing of the procedure and the selection of the most effective surgical strategy.

6 November 2025 in PLOS ONE
Verified
Journal Article
Open access
RSRaphael Seiler
Raphael Seiler
NSNehle Speckmann
Nehle Speckmann
CTCamilo Jose Hernandez Toro
Camilo Jose Hernandez Toro
DHDörte Huscher
Dörte Huscher
FBFelix Berger
Felix Berger
OMOliver Miera
Oliver Miera
Background: Mechanical circulatory support with ventricular assist device (VAD) is a life-saving therapy in children with end-stage heart failure. Infections are a major problem in VAD-therapy and may lead to significant morbidity and mortality. The aim of the study was to evaluate possible risk factors for superficial percutaneous lead/canula infections (SI) and to determine their impact on overall outcome during VAD-therapy. Methods: Single center, retrospective analysis of infectious complications in 70 consecutive children supported on a VAD (58 Berlin Heart EXCOR Pediatric pulsatile flow pump and 12 Heartware continuous flow pump). Cox proportional hazard models with SI, bloodstream infections, and stroke as outcome, as well as a competing risk model for device weaning, death, and heart transplantation were used to identify risk factors in the study population. Results: SI were documented in twelve out of 70 children (17%). The event rate for SI was 5.86 per 100 patient months [95%CI 3.03–10.23] with a median time to SI of 109 days [IQR 66–163]. The occurrence of SI was mostly in patients with longer support times while the underlying diagnosis and previous thoracotomies had no impact on the number of SI. Further, children older than three years of age had a higher risk for SI (HR 2.67; 95% CI 1.09–6.57, p = 0.032). SI were not associated with the risk of bloodstream infections (HR 1.27; 95%CI 0.44–3.67, p = 0.656) or death (HR 0.32; 95% CI 0.06–1.80, p = 0.194). Conclusions: SI occurred frequently during VAD therapy in children, without leading to a higher rate of bloodstream infections or mortality. Further, being above three years of age at VAD implantation was associated with increased risk to develop SI.

18 December 2025 in European Heart Journal - Imaging Methods and Practice
Verified
Journal Article
Open access
RSRaphael Seiler
Raphael Seiler
FGFelix Günther
Felix Günther
AHAlexandra Hinke
Alexandra Hinke
FGFlorian Gross
Florian Gross
TLTeresa Lerach
Teresa Lerach
SOStanislav Ovrutskiy
Stanislav Ovrutskiy
Aims: Assessment of right ventricular volume is crucial for monitoring patients with congenital heart defects. However, due to the right ventricle’s complex geometry, 2D echocardiography is challenging and MRI is commonly used to evaluate right ventricular volume. However, MRI has several limitations: it lacks bedside imaging, is time-consuming, and often requires sedation in patients with congenital heart defects. Therefore, we aimed to develop a reliable and simple method for calculating right ventricular volume using 2D echocardiography. Methods and results: Standard apical 4-chamber and parasternal short-axis views were obtained using 2D echocardiography in 40 congenital heart defects patients. Right ventricular volumes were calculated using an ellipsoidal shell model, a truncated cone model and a novel approach based on a cone model: VRV=23(ASAX+18πdTV2)A4CHdTV. The results were compared with right ventricular volumes obtained via MRI. The proposed cone-based model demonstrated excellent correlation to right ventricular volumes obtained by MRI (systolic: ICC = 0.98 (95% CI 0.95–0.99)/diastolic: ICC = 0.96 (95% CI 0.92–0.98)). The mean difference from MRI-measured systolic volume was 0.1 mL (SD ± 13.3) and from diastolic volume 5.2 mL (SD ± 28.2). Based on the root mean square error (RMSE) our cone model (RMSE 13.2 mL/28.4 mL systolic/diastolic) demonstrates significantly better predictive accuracy than the traditional ellipsoidal shell model (RMSE 20.8 mL/52.6 mL systolic/diastolic) and the truncated cone model (RMSE 25.1 mL/42.3 mL systolic/diastolic). Conclusion: Our method shows excellent alignment with MRI data. It offers an accurate and rapid method for bedside assessment of right ventricular volume with 2D echocardiography, enhancing prompt and precise clinical decision-making.

19 May 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
SSSashko G. Spassov
Sashko G. Spassov
SFSimone Faller
Simone Faller
AGAndreas Goeft
Andreas Goeft
MIMarc-Nicolas A. Von Itter
Marc-Nicolas A. Von Itter
ABAndreas Birkigt
Andreas Birkigt
AHAlexander Hoetzel
Alexander Hoetzel
Hydrogen sulfide (H2S) protects against stretch-induced lung injury. However, the impact of H2S on individual cells or their crosstalk upon stretch remains unclear. Therefore, we addressed this issue in vitro using relevant lung cells. We have explored (i) the anti-inflammatory properties of H2S on epithelial (A549 and BEAS-2B), macrophage (RAW264.7) and endothelial (HUVEC) cells subjected to cycling mechanical stretch; (ii) the intercellular transduction of inflammation by co-culturing epithelial cells and macrophages (A549 and RAW264.7); (iii) the effect of H2S on neutrophils (Hoxb8) in transmigration (co-culture setup with HUVECs) and chemotaxis experiments. In stretched epithelial cells (A549, BEAS-2B), the release of interleukin-8 was not prevented by H2S treatment. However, H2S reduced macrophage inflammatory protein-2 (MIP-2) release from unstretched macrophages (RAW264.7) co-cultured with stretched epithelial cells. In stretched macrophages, H2S prevented MIP-2 release by limiting nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide radicals (ROS). In endothelial cells (HUVEC), H2S inhibited interleukin-8 release and preserved endothelial integrity. In neutrophils (Hoxb8), H2S limited MIP-2-induced transmigration through endothelial monolayers, ROS formation and their chemotactic movement. H2S induces anti-inflammatory effects in a cell-type specific manner. H2S limits stretch- and/or paracrine-induced inflammatory response in endothelial, macrophage, and neutrophil cells by maintaining redox homeostasis as underlying mechanism.

Verified
Journal Article
Open access
PDF file
FGFlorian Gross
Florian Gross
RDRobert Dragendorf
Robert Dragendorf
TLTeresa Lerach
Teresa Lerach
AHAlexandra Hinke
Alexandra Hinke
FBFelix Berger
Felix Berger
SOStanislav Ovrutskiy
Stanislav Ovrutskiy
Background/Objectives: Accurate quantification of left-to-right shunt volume is central to clinical decision-making in patients with atrial septal defect (ASD). Conventional echocardiographic Qp:Qs estimation is widely used but limited by operator dependency, Doppler alignment sensitivity, and the quadratic amplification of diameter measurement errors in flow calculations. These factors contribute to clinically relevant variability, particularly in paediatric populations with small vessel dimensions. Simulation-based haemodynamic modelling offers an alternative approach by integrating structural and functional cardiac parameters within a patient-specific computational framework, independent of direct Doppler flow measurements. Methods: This retrospective single-centre study evaluated agreement between conventional Doppler-derived and software-based Qp:Qs quantification using a three-dimensional haemodynamic simulation model. Transthoracic echocardiographic datasets from patients with isolated secundum ASD undergoing defect closure between 2018 and 2024 were analysed. Conventional Qp:Qs was calculated using pulmonary and aortic valve diameter and velocity–time integral measurements, while software-derived Qp:Qs was computed from patient-specific haemodynamic modelling based on cardiac chamber geometry and physiological parameters. Mean values were compared using Student’s t-test. Agreement was assessed using Bland–Altman analysis. A predefined ± 20% deviation threshold was considered clinically acceptable according to the study protocol. Results: A total of 98 echocardiographic examinations from 94 patients were included. Mean Qp:Qs was 1.83 ± 0.45 by echocardiography and 1.73 ± 0.47 by simulation modelling, with no statistically significant difference between methods (p Using the predefined ± 20% deviation criterion, 53.1% of examinations fell within the acceptable range. Larger ASD diameter was associated with increased inter-method deviation. Conclusions: This study provides an initial feasibility evaluation of a novel haemodynamic simulation approach enabling patient-specific three-dimensional modelling of cardiac structures and shunt physiology based on routine echocardiographic data. Simulation-derived Qp:Qs estimates demonstrated no systematic difference in comparison with conventional Doppler-based quantification and were feasible within routine clinical workflows. Ongoing prospective validation against invasive haemodynamic reference standards will further define analytical accuracy and potential clinical applicability.